Skip to main content
. 2016 Sep 23;52(3):173–184. doi: 10.4068/cmj.2016.52.3.173

TABLE 2. Strategies for attenuated S. typhimurium-mediated cancer therapy.

graphic file with name cmj-52-173-i002.jpg

CD: E.coli cytosine deaminase, CPG2: carboxypeptidase G2, ePNR: E. coli purine nucleoside phosphorylase, flk1: fetal liver kinase 1, gp100: glycoprotein 100, GRIM-19: gene associated with retinoid-interferon-induced mortality-19, HSV1-tk: herpes simplex virus type 1 thymidine kinase, IDO: indoleamine 2,3-dioxygenase, mdm2: murine double minute 2, MDR1: multidrug-resistance gene, MTD: mitochondrial-targeting domain, MTDH/AEG-1: metadherin/astrocyte elevated gene-1, mtHSP70: mycobacterium tuberculosis heat shock protein 70, p53: tumor protein p53, SPYR: sprouty proteins, Stat3: signal transducer and activator of transcription 3.